Data as of Dec 06
| -0.15 / -3.01%|
The 3 analysts offering 12-month price forecasts for Alexza Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 7.00. The median estimate represents a +107.04% increase from the last price of 4.83.
The current consensus among 3 polled investment analysts is to Buy stock in Alexza Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.